Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

8.0%

2 terminated/withdrawn out of 25 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
8(88.9%)
Phase 4
1(11.1%)
9Total
N/A(8)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials
NCT07538882Recruiting

AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma

Role: collaborator

NCT06541106Recruiting

Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China

Role: collaborator

NCT06943729Recruiting

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Role: collaborator

NCT06418464Not ApplicableNot Yet Recruiting

Efficacy and Safety of an Artificial-pancreas-like Learning-based Control in Type 1 Diabetes on Multiple Daily Injection Therapy

Role: collaborator

NCT06103890Unknown

Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Role: collaborator

NCT06082414Completed

Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants

Role: collaborator

NCT04307264Completed

CHESS Criteria for Varices Screening in Compensated Advanced Chronic Liver Disease (CHESS2001/APPHA2001)

Role: collaborator

NCT04121520Completed

Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey

Role: collaborator

NCT05439577Unknown

A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema

Role: collaborator

NCT03938311Not ApplicableUnknown

Time Window for Ischemic Stroke First Mobilization Effectiveness

Role: collaborator

NCT05204602Unknown

Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases

Role: collaborator

NCT03990753Unknown

Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901)

Role: collaborator

NCT03778775Unknown

Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (Pan-CHESS1801)

Role: collaborator

NCT03713606Unknown

Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802)

Role: collaborator

NCT03783065Not ApplicableUnknown

HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)

Role: collaborator

NCT04028323Phase 4Unknown

Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)

Role: collaborator

NCT04329559Completed

COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study

Role: collaborator

NCT03766880Not ApplicableCompleted

MR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)

Role: collaborator

NCT03373123Not ApplicableWithdrawn

Radiomics-based Surrogate of Endoscopy (rEndosc) (CHESS1703)

Role: collaborator

NCT03953638Unknown

Application of Next Generation Sequencing Technique in Pediatric Bacterial Meningitis

Role: collaborator